Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Cognitions significantly influence Trichotillomania, suggesting cognitive therapies could help.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Chinese and Japanese bloggers discuss different topics and have varying opinions, reflecting cultural differences.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

Some chemicals absorbed through the skin can cause serious health problems.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Lupus patients' body image issues significantly affect their mental health and need more support.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The lump on a woman's scalp was a rare, potentially cancerous tumor from the hair follicle, not a common cyst.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

PRP improves hair thickness for both genders, but only increases hair density in men.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Post-implantation erythema is a red skin condition after medical device implantation that sometimes goes away on its own.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

The book teaches how to diagnose hair loss, prepare patients, perform hair restoration surgeries, and discusses future techniques like hair follicle cloning.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Melatonin implants did not effectively prevent hair loss in dogs.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.